Kapstone Financial Advisors LLC Pfizer Inc Transaction History

Kapstone Financial Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$25.89 - $29.73 $40,983 - $47,062	-1,583 Reduced 16.07%	8,266 $229 Million
Q4 2023 Feb 05, 2024	SELL	$26.13 - $33.94 $57,015 - $74,057	-2,182 Reduced 18.14%	9,849 $271 Million
Q3 2023 Nov 03, 2023	BUY	$32.09 - $37.51 $4,460 - $5,213	139 Added 1.17%	12,031 $399 Million
Q2 2023 Aug 08, 2023	BUY	$36.12 - $41.79 $52,048 - $60,219	1,441 Added 13.79%	11,892 $423 Million
Q1 2023 Apr 20, 2023	BUY	$39.39 - $51.28 $25,485 - $33,178	647 Added 6.6%	10,451 $433 Million
Q4 2022 Feb 15, 2023	BUY	$41.75 - $54.5 $409,317 - $534,318	9,804 New	9,804 $435 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Kapstone Financial Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Kapstone Financial Advisors LLC with notifications on news.